One mechanism is the release of large amounts of proinflammatory and vasoactive substances, such as interleukins IL-1, IL-6, and tumor necrosis factor (TNF)-α, which are involved in gallbladder inflammatory disorders and the pathogenesis of GSD [81]. This evidence concerns the gene TNF and disorder of glycogen metabolism.